NCT04150341
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Theravance Biopharma Investigational Site London, United Kingdom
- Theravance Biopharma Investigational Site Manchester, United Kingdom
Clinical trial condition
Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.
NCT04150341
NCT04078126
NCT04014868
NCT03015090
NCT05277610
NCT05274490
NCT03883594
NCT03855670
NCT04613739
NCT02215122